A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy (Q50586139)
scientific article published in January 2001
Language:
Current Data About A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy
(P31) (Q13442814)
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P50) (Q40532542)
(P1545) 9
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P304) 128-133
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P433) 1
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P478) 34
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P577) Monday, January 1, 2001
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P921) (Q421862)
(P887)

(Q55779873)
(P887)

(P1433) (Q15724402)
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P1476) "A randomized, double-blind controlled trial of interferon alpha-2b and ribavirin vs. interferon alpha-2b and amantadine for treatment of chronic hepatitis C non-responder to interferon monotherapy" (language: en)
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P2093) Z M Younossi
(P1545) 1
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

K D Mullen
(P1545) 2
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

W Zakko
(P1545) 3
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

S Hodnick
(P1545) 4
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

E Brand
(P1545) 5
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

D S Barnes
(P1545) 6
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

W D Carey
(P1545) 7
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

A C McCullough
(P1545) 8
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

N Boparai
(P1545) 10
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

T Gramlich
(P1545) 11
(P248)
(P698) 11211889
(P813) Friday, March 16, 2018
(P854) http://europepmc.org/abstract/MED/11211889

(P2860) (Q29620136)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q33871639)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q41598735)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q35960890)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q44765507)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q27861083)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q41839327)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q43036080)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q40435912)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q41332870)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q42990190)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q42985646)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q50851322)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q50587404)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q42996746)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

(Q33973199)
(P248)
(P854) https://api.crossref.org/works/10.1016%2FS0168-8278%2800%2900003-9
(P813) Thursday, January 7, 2021
(P887)

other details
description scientific article published in January 2001

External Links
(P356) 10.1016/S0168-8278(00)00003-9
(P698) 11211889